Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
37.82
-1.15 (-2.95%)
At close: Oct 1, 2025, 4:00 PM EDT
38.20
+0.38 (1.00%)
After-hours: Oct 1, 2025, 7:36 PM EDT
Tvardi Therapeutics Market Cap
Tvardi Therapeutics has a market cap or net worth of $354.65 million as of October 1, 2025. Its market cap has increased by 2,362.88% in one year.
Market Cap
354.65M
Enterprise Value
313.91M
1-Year Change
2,362.88%
Ranking
Category
Stock Price
$37.82
Market Cap Chart
Since January 31, 2014, Tvardi Therapeutics's market cap has increased from $282.00M to $354.65M, an increase of 25.76%. That is a compound annual growth rate of 1.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 365.40M | 1,205.00% |
| Dec 31, 2024 | 28.00M | -30.86% |
| Dec 29, 2023 | 40.50M | -92.98% |
| Dec 30, 2022 | 577.10M | -11.37% |
| Dec 31, 2021 | 651.10M | -13.65% |
| Dec 31, 2020 | 754.00M | 0.27% |
| Dec 31, 2019 | 752.00M | 46.65% |
| Dec 31, 2018 | 512.80M | 28.49% |
| Dec 29, 2017 | 399.10M | 57.44% |
| Dec 30, 2016 | 253.50M | -44.78% |
| Dec 31, 2015 | 459.10M | 102.16% |
| Dec 31, 2014 | 227.10M | -19.47% |
| Jan 31, 2014 | 282.00M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 649.70B |
| Johnson & Johnson | 435.61B |
| AbbVie | 392.18B |
| UnitedHealth Group | 312.02B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 231.19B |
| AstraZeneca | 228.75B |